ctrl K

Price Alert

Serina Therapeutics Inc. (SER)

NYSE: SER · Real-Time Price · USD

5.28

-0.22 (-4.00%)

At close: Aug 15, 2025, 3:59 PM

5.41

2.46%

After-hours: Aug 15, 2025, 06:12 PM EDT

Serina Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	3.67M	345K	532.23K	314.85K
Short-Term Investments	n/a	n/a	n/a	996.45K
Long-Term Investments	n/a	10.6M	50K	n/a
Other Long-Term Assets	n/a	n/a	-788K	-870K
Receivables	n/a	57K	4K	1.11K
Inventory	n/a	n/a	n/a	n/a
Other Current Assets	77K	-57K	-4K	n/a
Total Current Assets	5.68M	7.62M	548.58K	1.33M
Property-Plant & Equipment	1.05M	n/a	309.47K	514.15K
Goodwill & Intangibles	n/a	607K	738K	870K
Total Long-Term Assets	1.05M	11.21M	309.47K	514.15K
Total Assets	6.72M	11.96M	858.04K	1.84M
Account Payables	744K	580K	143.34K	145.47K
Deferred Revenue	n/a	n/a	153.5K	n/a
Short-Term Debt	n/a	3.67M	n/a	7.14M
Other Current Liabilities	1.06M	1.66M	n/a	-7.14M
Total Current Liabilities	2.37M	5.91M	437.69K	371.47K
Long-Term Debt	n/a	693K	1.62M	6.06M
Other Long-Term Liabilities	3.58M	n/a	36.52M	36.39M
Total Long-Term Liabilities	3.85M	693K	38.2M	36.58M
Total Liabilities	6.22M	6.61M	38.64M	36.95M
Total Debt	268K	4.37M	1.81M	398.17K
Common Stock	1K	n/a	4K	4K
Retained Earnings	-44.32M	-131.01M	-116.21M	-105.75M
Comprehensive Income	n/a	n/a	n/a	n/a
Shareholders Equity	641K	5.47M	-17.21M	-11.83M
Total Investments	n/a	10.6M	50K	996.45K